CNMD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide...

Stats
Today's Volume	408 145
Average Volume	529 458
Market Cap	2.30B
EPS	$1.060 ( 2024-04-24 )
Next earnings date	( $0.920 ) 2024-07-24
Last Dividend	$0.200 ( 2023-12-15 )
Next Dividend	$0 ( N/A )
P/E	28.63
ATR14	$0.0550 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-13	Bronson David M	Buy	1 350	Common Stock
2024-05-08	Schwarzentraub Barbara J	Buy	1 442	Common Stock
2024-05-06	Aronson Martha Goldberg	Buy	2 000	Common Stock
2024-04-30	Beyer Pat	Buy	3 000	Common Stock
2024-04-24	Beyer Pat	Buy	20 060	Options To Purchase Common Stock

INSIDER POWER
44.15
Last 96 transactions
Buy: 445 289 \| Sell: 206 124

Volume Correlation

Long: -0.16 (neutral)

Short: -0.21 (neutral)

Signal:(36.12) Neutral

Conmed Corp Correlation

10 Most Positive Correlations
BWV	0.961
HUM	0.958
GNE	0.952
SAVE	0.952
LL	0.951
BA	0.95
TCS	0.949
WE	0.947
YALA	0.942
FUBO	0.94

10 Most Negative Correlations
MIT	-0.965
IRL	-0.956
GSQB	-0.947
MTVC	-0.942
ESMT	-0.939
TDG	-0.938
HRC	-0.937
BSX	-0.936
DMYS	-0.936
MITT-PC	-0.934

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Conmed Corp Correlation - Currency/Commodity

-0.12
( neutral )

0.21
( neutral )

0.00
( neutral )

0.04
( neutral )

0.06
( neutral )

Conmed Corp Financials

Annual	2023
Revenue:	$1.24B
Gross Profit:	$643.07M (51.82 %)
EPS:	$2.10

FY	2023
Revenue:	$1.24B
Gross Profit:	$643.07M (51.82 %)
EPS:	$2.10

FY	2022
Revenue:	$1.05B
Gross Profit:	$571.25M (54.64 %)
EPS:	$-2.68

FY	2021
Revenue:	$1.01B
Gross Profit:	$568.04M (56.21 %)
EPS:	$2.14

Financial Reports:

No articles found.

Conmed Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Conmed Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.66 - Increase likely (53.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2012-03-13
Last Dividend	$0.200	2023-12-15
Next Dividend	$0	N/A
Payout Date	2024-01-05
Next Payout Date	N/A
# dividends	48	--
Total Paid Out	$9.25	--
Avg. Dividend % Per Year	0.49%	--
Score	4.92	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.66
Div. Directional Score	9.16	--

Next Divdend (Est)
(2024-07-01)

$0.203 Estimate 40.00 %

Dividend Stability

0.80 Very Good

Dividend Score

4.92

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.600	2.31%
2013	$0.650	2.32%
2014	$0.800	1.87%
2015	$0.800	1.78%
2016	$0.800	1.88%
2017	$0.800	1.81%
2018	$0.800	1.58%
2019	$0.800	1.26%
2020	$0.800	0.72%
2021	$0.800	0.72%
2022	$0.800	0.55%
2023	$0.800	0.89%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
MTR	Dividend Royal	2023-10-30	Monthly	39	10.10%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0653	1.500	8.69	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0357	1.200	8.81	10.00	[0 - 0.3]
returnOnEquityTTM	0.101	1.500	9.99	10.00	[0.1 - 1]
payoutRatioTTM	0.298	-1.000	7.02	-7.02	[0 - 1]
currentRatioTTM	2.18	0.800	4.09	3.27	[1 - 3]
quickRatioTTM	0.945	0.800	9.15	7.32	[0.8 - 2.5]
cashRatioTTM	0.116	1.500	-0.466	-0.699	[0.2 - 2]
debtRatioTTM	0.429	-1.500	2.85	-4.27	[0 - 0.6]
interestCoverageTTM	3.66	1.000	9.76	9.76	[3 - 30]
operatingCashFlowPerShareTTM	5.14	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.60	2.00	7.70	10.00	[0 - 20]
debtEquityRatioTTM	1.159	-1.500	5.36	-8.04	[0 - 2.5]
grossProfitMarginTTM	0.543	1.000	4.28	4.28	[0.2 - 0.8]
operatingProfitMarginTTM	0.113	1.000	9.73	9.73	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.160	1.000	-0.223	-0.223	[0.2 - 2]
assetTurnoverTTM	0.546	0.800	9.69	7.75	[0.5 - 2]
Total Score				10.65

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	27.86	1.000	7.29	0	[1 - 100]
returnOnEquityTTM	0.101	2.50	9.99	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.60	2.00	8.47	10.00	[0 - 30]
dividendYielPercentageTTM	1.073	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.14	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	0.298	1.500	7.02	-7.02	[0 - 1]
pegRatioTTM	3.76	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.126	1.000	9.36	0	[0.1 - 0.5]
Total Score				7.66

Conmed Corp Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Conmed Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.